Edward Tenthoff
Stock Analyst at Piper Sandler
(4.33)
# 1,317
Out of 4,676 analysts
1263
Total ratings
42.5%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Reiterated: Buy | $6 → $8 | $2.55 | +213.73% | 38 | Aug 14, 2026 | |
| CAPR Capricor Therapeutics | Maintained: Hold | $2 | $8.29 | -75.87% | 16 | Aug 14, 2026 | |
| BMEA Biomea Fusion | Reiterated: Buy | $7 | $1.73 | +304.62% | 7 | Aug 14, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $12 → $15 | $4.45 | +237.08% | 14 | Aug 14, 2026 | |
| INO Inovio Pharmaceuticals | Reiterated: Buy | $4 | $1.29 | +210.08% | 9 | Aug 13, 2026 | |
| ACRV Acrivon Therapeutics | Reiterated: Buy | $8 | $2.18 | +266.97% | 6 | Aug 13, 2026 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $6 | $1.02 | +488.24% | 7 | Aug 12, 2026 | |
| CTMX CytomX Therapeutics | Reiterated: Buy | $12 | $3.37 | +256.08% | 10 | Aug 7, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $37 | $14.56 | +154.12% | 19 | Aug 7, 2026 | |
| GENB Generate Biomedicines | Reiterated: Buy | $24 | $20.38 | +17.76% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $29.30 | +12.63% | 47 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 | $158.83 | -51.52% | 112 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $88.88 | +41.76% | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.60 | +108.33% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $60.90 | +80.62% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $7 | $1.92 | +264.58% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $47 | $26.34 | +78.44% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.49 | +101.34% | 30 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $64 | $21.30 | +200.47% | 23 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.91 | +153.81% | 25 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.17 | +84.33% | 21 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $23 → $3 | $3.86 | -22.28% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $8.19 | +46.52% | 7 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $1.16 | +503.45% | 19 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $6 | $2.02 | +197.77% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $489 | $240.08 | +103.68% | 100 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $17.19 | +103.61% | 15 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $5.00 | +300.00% | 14 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $125 | $126.64 | -1.30% | 21 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $21.44 | -6.72% | 28 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $26.76 | n/a | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $1.11 | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $4.16 | n/a | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 20 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $4.39 | n/a | 14 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.5 | $19.00 | n/a | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $13 | $0.57 | n/a | 10 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.3 | $0.0001 | n/a | 6 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $38 | $107.36 | n/a | 8 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $44 | $16.20 | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $13 | $2.46 | n/a | 14 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $60 | $19.29 | n/a | 15 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $323 | $552.85 | n/a | 49 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $9 | $1.21 | n/a | 9 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $40 | $77.46 | n/a | 17 | Aug 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $56.72 | n/a | 34 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $309 → $250 | $1,019.49 | n/a | 21 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €264.52 | €872.80 | n/a | 1 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $1.5 | $0.1973 | n/a | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.5 | $1.52 | n/a | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $70 → $90 | $148.77 | n/a | 3 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0001 | n/a | 4 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $60 | $4.16 | n/a | 6 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $208 | $18.92 | n/a | 44 | Jun 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $14.34 | n/a | 1 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $90 → $5 | $9.44 | n/a | 23 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.000001 | n/a | 1 | Dec 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $19 | $43.22 | n/a | 5 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $0.2101 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $0.1 | $0.0001 | n/a | 8 | Mar 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $5 | $0.000001 | n/a | 9 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $557 | $833.56 | n/a | 35 | Sep 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $0.2916 | n/a | 6 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $5.60 | n/a | 5 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $83.62 | n/a | 1 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.000001 | n/a | 1 | Jul 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $20 | $63.57 | n/a | 1 | Jul 23, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.8614 | n/a | 1 | Mar 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.59 | n/a | 1 | Feb 20, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $2.5 | $14.09 | n/a | 1 | Dec 31, 2012 |
Fate Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $2.55
Upside: +213.73%
Capricor Therapeutics
Aug 14, 2026
Maintained: Hold
Price Target: $2
Current: $8.29
Upside: -75.87%
Biomea Fusion
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $1.73
Upside: +304.62%
Camp4 Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $12 → $15
Current: $4.45
Upside: +237.08%
Inovio Pharmaceuticals
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.29
Upside: +210.08%
Acrivon Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $2.18
Upside: +266.97%
Cardiff Oncology
Aug 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.02
Upside: +488.24%
CytomX Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $3.37
Upside: +256.08%
Monte Rosa Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $37
Current: $14.56
Upside: +154.12%
Generate Biomedicines
Aug 7, 2026
Reiterated: Buy
Price Target: $24
Current: $20.38
Upside: +17.76%
Aug 6, 2026
Reiterated: Buy
Price Target: $33
Current: $29.30
Upside: +12.63%
Aug 6, 2026
Reiterated: Buy
Price Target: $77
Current: $158.83
Upside: -51.52%
Aug 5, 2026
Reiterated: Buy
Price Target: $126
Current: $88.88
Upside: +41.76%
Aug 5, 2026
Reiterated: Buy
Price Target: $20
Current: $9.60
Upside: +108.33%
Aug 4, 2026
Reiterated: Buy
Price Target: $110
Current: $60.90
Upside: +80.62%
Jul 31, 2026
Maintained: Buy
Price Target: $16 → $7
Current: $1.92
Upside: +264.58%
Jul 30, 2026
Reiterated: Buy
Price Target: $45 → $47
Current: $26.34
Upside: +78.44%
Jul 28, 2026
Reiterated: Buy
Price Target: $3
Current: $1.49
Upside: +101.34%
Jun 15, 2026
Reiterated: Buy
Price Target: $64
Current: $21.30
Upside: +200.47%
Jun 10, 2026
Maintained: Buy
Price Target: $15
Current: $5.91
Upside: +153.81%
Jun 9, 2026
Reiterated: Buy
Price Target: $4
Current: $2.17
Upside: +84.33%
Jun 2, 2026
Downgraded: Sell
Price Target: $23 → $3
Current: $3.86
Upside: -22.28%
Jun 1, 2026
Reiterated: Buy
Price Target: $12
Current: $8.19
Upside: +46.52%
May 14, 2026
Reiterated: Buy
Price Target: $4 → $7
Current: $1.16
Upside: +503.45%
May 12, 2026
Rated: Buy
Price Target: $13 → $6
Current: $2.02
Upside: +197.77%
May 1, 2026
Reiterated: Buy
Price Target: $489
Current: $240.08
Upside: +103.68%
Apr 10, 2026
Reiterated: Buy
Price Target: $35
Current: $17.19
Upside: +103.61%
Feb 13, 2026
Maintained: Hold
Price Target: $20
Current: $5.00
Upside: +300.00%
Dec 9, 2025
Reiterated: Buy
Price Target: $98 → $125
Current: $126.64
Upside: -1.30%
Dec 4, 2025
Reiterated: Buy
Price Target: $20
Current: $21.44
Upside: -6.72%
Apr 1, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $26.76
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $65
Current: $1.11
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $60
Current: $4.16
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $52
Current: $4.39
Upside: n/a
Aug 17, 2023
Maintained: Hold
Price Target: $0.5
Current: $19.00
Upside: n/a
Apr 11, 2023
Maintained: Buy
Price Target: $9 → $13
Current: $0.57
Upside: n/a
Feb 23, 2023
Downgraded: Hold
Price Target: $3 → $0.3
Current: $0.0001
Upside: n/a
Oct 27, 2022
Upgraded: Buy
Price Target: $1 → $38
Current: $107.36
Upside: n/a
Aug 25, 2022
Maintained: Buy
Price Target: $37 → $44
Current: $16.20
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $20 → $13
Current: $2.46
Upside: n/a
May 23, 2022
Maintained: Buy
Price Target: $160 → $60
Current: $19.29
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $323
Current: $552.85
Upside: n/a
Sep 20, 2021
Maintained: Buy
Price Target: $7 → $9
Current: $1.21
Upside: n/a
Aug 8, 2021
Maintained: Buy
Price Target: $42 → $40
Current: $77.46
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $36
Current: $56.72
Upside: n/a
Jun 7, 2021
Maintained: Hold
Price Target: $309 → $250
Current: $1,019.49
Upside: n/a
Feb 4, 2021
Maintained: Hold
Price Target: €264.52
Current: €872.80
Upside: n/a
Jun 30, 2020
Reiterated: Buy
Price Target: $3 → $1.5
Current: $0.1973
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: $5 → $2.5
Current: $1.52
Upside: n/a
Mar 20, 2020
Upgraded: Buy
Price Target: $70 → $90
Current: $148.77
Upside: n/a
Dec 11, 2019
Maintained: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Sep 5, 2019
Rated: Hold
Price Target: $5 → $60
Current: $4.16
Upside: n/a
Jun 21, 2019
Reiterated: Buy
Price Target: $200 → $208
Current: $18.92
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: $32
Current: $14.34
Upside: n/a
Feb 28, 2019
Downgraded: Sell
Price Target: $90 → $5
Current: $9.44
Upside: n/a
Dec 12, 2018
Reiterated: Buy
Price Target: $30
Current: $0.000001
Upside: n/a
Nov 6, 2018
Maintained: Buy
Price Target: $16 → $19
Current: $43.22
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $0.2101
Upside: n/a
Mar 12, 2018
Downgraded: Sell
Price Target: $4 → $0.1
Current: $0.0001
Upside: n/a
Nov 2, 2017
Maintained: Buy
Price Target: $17 → $5
Current: $0.000001
Upside: n/a
Sep 11, 2017
Reiterated: Buy
Price Target: $557
Current: $833.56
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $5 → $4
Current: $0.2916
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $1
Current: $5.60
Upside: n/a
Aug 18, 2016
Reiterated: Buy
Price Target: $35
Current: $83.62
Upside: n/a
Jul 9, 2015
Downgraded: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Jul 23, 2013
Downgraded: Sell
Price Target: $20
Current: $63.57
Upside: n/a
Mar 4, 2013
Rated: Buy
Price Target: $6
Current: $0.8614
Upside: n/a
Feb 20, 2013
Maintained: Buy
Price Target: $6
Current: $1.59
Upside: n/a
Dec 31, 2012
Rated: Buy
Price Target: $2.5
Current: $14.09
Upside: n/a